[Current status of diagnosis and treatment of hepatoblastoma].
García-Miguel
Purificación
P
Unidad de Oncología Pediátrica, Hospital Universitario La Paz, Madrid, España. mlopez.hulp@salud.madrid.org
López Santamaría
Manuel
M
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D014408:Biomarkers, Tumor / Q000097:blood; D003131:Combined Modality Therapy; D006498:Hepatectomy; D018197:Hepatoblastoma / Q000175:diagnosis* / Q000235:genetics / Q000473:pathology / Q000556:secondary / Q000628:therapy*; D006801:Humans; D007223:Infant; D007230:Infant, Low Birth Weight; D007231:Infant, Newborn; D008113:Liver Neoplasms / Q000175:diagnosis* / Q000235:genetics / Q000473:pathology / Q000628:therapy*; D016031:Liver Transplantation; D008175:Lung Neoplasms / Q000556:secondary; D009367:Neoplasm Staging / Q000379:methods; D009386:Neoplastic Syndromes, Hereditary / Q000235:genetics; D014314:Trisomy; D000509:alpha-Fetoproteins / Q000032:analysis; D051176:beta Catenin / Q000235:genetics
D014408:Biomarkers, Tumor; D000509:alpha-Fetoproteins; D051176:beta Catenin